UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Teleflex Incorporated (NYSE:TFX)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 12.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 373,388 shares of the medical technology company's stock after acquiring an additional 40,128 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.80% of Teleflex worth $66,456,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in TFX. Voloridge Investment Management LLC acquired a new position in Teleflex in the fourth quarter valued at about $5,707,000. Worldquant Millennium Advisors LLC bought a new position in shares of Teleflex in the fourth quarter valued at about $3,229,000. Squarepoint Ops LLC lifted its holdings in Teleflex by 5,276.0% during the 4th quarter. Squarepoint Ops LLC now owns 68,168 shares of the medical technology company's stock worth $12,133,000 after buying an additional 66,900 shares in the last quarter. Tidal Investments LLC boosted its position in Teleflex by 14.5% in the 4th quarter. Tidal Investments LLC now owns 9,177 shares of the medical technology company's stock valued at $1,633,000 after buying an additional 1,163 shares during the last quarter. Finally, True Wealth Design LLC raised its position in shares of Teleflex by 62.3% during the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock worth $48,000 after acquiring an additional 104 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Down 0.4%

Shares of NYSE:TFX traded down $0.52 during trading on Friday, reaching $122.01. 107,173 shares of the stock were exchanged, compared to its average volume of 628,345. The firm has a market cap of $5.39 billion, a price-to-earnings ratio of 24.35, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The stock has a fifty day moving average of $129.94 and a two-hundred day moving average of $157.99. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 1-year low of $119.08 and a 1-year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $700.67 million during the quarter, compared to analyst estimates of $699.37 million. During the same period in the prior year, the firm posted $3.21 EPS. Teleflex's quarterly revenue was down 5.0% compared to the same quarter last year. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a yield of 1.11%. Teleflex's dividend payout ratio (DPR) is presently 42.90%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on TFX. Bank of America cut Teleflex from a "neutral" rating to an "underperform" rating and decreased their price objective for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. Royal Bank of Canada lowered their price objective on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a research report on Friday, May 2nd. Mizuho set a $155.00 target price on shares of Teleflex in a report on Wednesday, April 16th. Finally, Truist Financial reduced their target price on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.